Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
09 2023
Historique:
revised: 15 11 2022
received: 30 06 2022
accepted: 29 12 2022
medline: 31 8 2023
pubmed: 4 1 2023
entrez: 3 1 2023
Statut: ppublish

Résumé

The gouty tophus is an organized structure composed of monosodium urate (MSU) crystals and chronic inflammatory soft tissue. This dual-energy computed tomography (DECT) study aimed to determine whether the composition of the tophus changes during urate-lowering therapy. Serial DECT scans from 32 people with gout were obtained over 2 years of allopurinol therapy, dose-escalated to serum urate of <0.36 mmoles/liter. Up to 5 index tophi were selected for each patient, with 103 separate tophi included in the analysis. Using manual outlining methods of conventional CT and DECT scans, the same index tophi were serially measured for total tophus volume and urate volume. For each tophus, the soft tissue volume was then calculated by subtracting the urate volume from the total tophus volume. The mean ± SD serum urate reduced from 0.43 ± 0.03 mmoles/liter at baseline to 0.31 ± 0.02 mmoles/liter at year 2. The mean ± SD total tophus volume reduced over the 2-year period from 5.17 ± 5.55 cm The composition of the tophus is dynamic and changes during urate-lowering therapy for gout management. The soft tissue component of the tophus is slower to respond and may persist without measurable MSU crystal deposition.

Identifiants

pubmed: 36594401
doi: 10.1002/acr.25084
doi:

Substances chimiques

Uric Acid 268B43MJ25
Allopurinol 63CZ7GJN5I
Gout Suppressants 0

Banques de données

ANZCTR
['ACTRN12611000845932']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1949-1954

Informations de copyright

© 2023 The Authors. Arthritis Care & Research published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

Références

Aati O, Taylor WJ, Horne A, et al. Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout. J Clin Rheumatol 2014;20:251-5.
Dalbeth N, Clark B, Gregory K, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis 2009;68:1290-5.
Dalbeth N, Pool B, Gamble GD, et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010;62:1549-56.
Sapsford M, Gamble GD, Aati O, et al. Relationship of bone erosion with the urate and soft tissue components of the tophus in gout: a dual energy computed tomography study. Rheumatology (Oxford) 2017;56:129-33.
Dalbeth N, Aati O, Gao A, et al. Assessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanning. J Clin Rheumatol 2012;18:23-7.
Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60.
Dalbeth N, Billington K, Doyle A, et al. Effects of allopurinol dose escalation on bone erosion and urate volume in gout: a dual-energy computed tomography imaging study within a randomized, controlled trial. Arthritis Rheumatol 2019;71:1739-46.
Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
Dalbeth N, Clark B, Gregory K, et al. Computed tomography measurement of tophus volume: comparison with physical measurement. Arthritis Rheum 2007;57:461-5.
Larmon WA, Kurtz JF. The surgical management of chronic tophaceous gout. J Bone Joint Surg Am 1958;40-A:743-72.
Hammer HB, Karoliussen L, Terslev L, et al. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study. Ann Rheum Dis 2020;79:1500-5.
Modjinou DV, Krasnokutsky S, Gyftopoulos S, et al. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking. Clin Rheumatol 2017;36:2101-7.
Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2017;76:29-42.
Mandell BF, Yeo AE, Lipsky PE. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase. Arthritis Res Ther 2018;20:286.
Ahn SJ, Zhang D, Levine BD, et al. Limitations of dual-energy CT in the detection of monosodium urate deposition in dense liquid tophi and calcified tophi. Skeletal Radiol 2021;50:1667-75.

Auteurs

Leanne Chen (L)

University of Auckland, Auckland, New Zealand.

Gregory D Gamble (GD)

University of Auckland, Auckland, New Zealand.

Anne Horne (A)

University of Auckland, Auckland, New Zealand.

Jill Drake (J)

University of Otago, Christchurch, New Zealand.

Anthony J Doyle (AJ)

Auckland District Health Board and University of Auckland, Auckland, New Zealand.

Till Uhlig (T)

Center for Treatment of Rheumatic and Musculoskeletal Diseases, Diakonhjemmet Hospital, Oslo, Norway.

Lisa K Stamp (LK)

University of Otago, Christchurch, New Zealand.

Nicola Dalbeth (N)

University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH